Mechanical properties and performances of contemporary drug-eluting stent: focus on the metallic backbone
暂无分享,去创建一个
Ply Chichareon | Yuki Katagiri | Taku Asano | Kuniaki Takahashi | Norihiro Kogame | Rodrigo Modolo | Erhan Tenekecioglu | Chun-Chin Chang | Mariusz Tomaniak | Neville Kukreja | Joanna J Wykrzykowska | Jan J Piek | Patrick W Serruys | Yoshinobu Onuma | P. Serruys | J. Wykrzykowska | J. Piek | P. Chichareon | R. Modolo | Kuniaki Takahashi | Chun-Chin Chang | M. Tomaniak | N. Kukreja | Y. Onuma | T. Asano | E. Tenekecioğlu | Y. Katagiri | Norihiro Kogame
[1] A. Roguin,et al. Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin Durable Polymer Everolimus-Eluting Stents. , 2018, Journal of the American College of Cardiology.
[2] P. Serruys,et al. Coronary stent thrombosis: what have we learned? , 2016, Journal of thoracic disease.
[3] Christian W Hamm,et al. Nickel and molybdenum contact allergies in patients with coronary in-stent restenosis , 2000, The Lancet.
[4] W. Carroll,et al. A platinum-chromium steel for cardiovascular stents. , 2010, Biomaterials.
[5] H. Ince,et al. Direct comparison of coronary bare metal vs. drug-eluting stents: same platform, different mechanics? , 2018, European Journal of Medical Research.
[6] P. Serruys,et al. Angiographic late lumen loss revisited: impact on long-term target lesion revascularization , 2018, European heart journal.
[7] G. Stone,et al. Long-Term Safety of Drug-Eluting and Bare-Metal Stents: Evidence From a Comprehensive Network Meta-Analysis. , 2015, Journal of the American College of Cardiology.
[8] F. Welt,et al. Inflammation and Restenosis in the Stent Era , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[9] S. Kische,et al. Sustained safety and clinical performance of a drug-eluting absorbable metal scaffold up to 24 months: pooled outcomes of BIOSOLVE-II and BIOSOLVE-III. , 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[10] J. Massaro,et al. Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial , 2017, The Lancet.
[11] P. Serruys,et al. An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-study. , 2010, European heart journal.
[12] R. Pettigrew,et al. Absence of movement of coronary stents after placement in a magnetic resonance imaging field. , 1994, The American journal of cardiology.
[13] K. Seung,et al. Predictors and Long-Term Clinical Outcome of Longitudinal Stent Deformation: Insights From Pooled Analysis of Korean Multicenter Drug-Eluting Stent Cohort , 2017, Circulation. Cardiovascular interventions.
[14] J. López-Sendón,et al. Clinical impact of in-stent late loss after drug-eluting coronary stent implantation. , 2007, European heart journal.
[15] A. Kastrati,et al. [Intracoronary Stenting and Angiographic Results Strut Thickness Effect on Restenosis Outcome (ISAR-STEREO) Trial]. , 2012, Vestnik rentgenologii i radiologii.
[16] Ryo Torii,et al. Local Hemodynamic Forces After Stenting: Implications on Restenosis and Thrombosis , 2017, Arteriosclerosis, thrombosis, and vascular biology.
[17] R Beyar,et al. Evaluation of the compressive mechanical properties of endoluminal metal stents. , 1998, Catheterization and cardiovascular diagnosis.
[18] G. Rioufol,et al. Mechanisms of stent thrombosis analysed by optical coherence tomography: insights from the national PESTO French registry. , 2016, European heart journal.
[19] M. Mamas,et al. Longitudinal deformation bench testing using a coronary artery model: a new standard? , 2017, Open Heart.
[20] Frank Witte,et al. The history of biodegradable magnesium implants: a review. , 2010, Acta biomaterialia.
[21] S. Windecker,et al. Drug-eluting stent technology: progress beyond the polymer. , 2014, European heart journal.
[22] G. Biondi-Zoccai,et al. Last nail in the coffin of late lumen loss? , 2008, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[23] F. Zijlstra,et al. Defining optimal stent overexpansion strategies for left main stenting : insights from bench testing , 2017 .
[24] C. Di Mario,et al. Maximal expansion capacity with current DES platforms: a critical factor for stent selection in the treatment of left main bifurcations? , 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[25] M. de Belder,et al. The SSTARS (STeroids and Stents Against Re-Stenosis) Trial: Different stent alloys and the use of peri-procedural oral corticosteroids to prevent in-segment restenosis after percutaneous coronary intervention. , 2016, International journal of cardiology.
[26] Deepthy Menon,et al. Nanotextured stainless steel for improved corrosion resistance and biological response in coronary stenting. , 2015, Nanoscale.
[27] Shuyang Zhang,et al. Over-expansion of drug-eluting stents in patients with left main coronary artery disease: An in vivo study , 2017, The Journal of international medical research.
[28] Renu Virmani,et al. Morphological Predictors of Restenosis After Coronary Stenting in Humans , 2002, Circulation.
[29] W. Lu,et al. Surface mechanical properties, corrosion resistance, and cytocompatibility of nitrogen plasma-implanted nickel-titanium alloys: a comparative study with commonly used medical grade materials. , 2007, Journal of biomedical materials research. Part A.
[30] Yufeng Zheng,et al. A review on biodegradable materials for cardiovascular stent application , 2016, Frontiers of Materials Science.
[31] R D Safian,et al. The Importance of Acute Luminal Diameter in Determining Restenosis After Coronary Atherectomy or Stenting , 1992, Circulation.
[32] H. Schunkert,et al. Outcomes of patients treated with durable polymer platinum-chromium everolimus-eluting stents: a meta-analysis of randomised trials. , 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[33] Michail I. Papafaklis,et al. Effects of Low Endothelial Shear Stress After Stent Implantation on Subsequent Neointimal Hyperplasia and Clinical Outcomes in Humans , 2016, Journal of the American Heart Association.
[34] Sun Kook Yoo,et al. A comparative reliability and performance study of different stent designs in terms of mechanical properties: foreshortening, recoil, radial force, and flexibility. , 2013, Artificial organs.
[35] R. Costa,et al. Comparison of acute stent recoil between the everolimus-eluting bioresorbable vascular scaffold and two different drug-eluting metallic stents , 2013 .
[36] M. S. Williams,et al. Stent and artery geometry determine intimal thickening independent of arterial injury. , 2000, Circulation.
[37] A. Kastrati,et al. Drug-eluting stents compared with thin-strut bare stents for the reduction of restenosis: a prospective, randomized trial. , 2005, European heart journal.
[38] R. Kempczinski. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty , 1987 .
[39] J. Ormiston,et al. Stent Longitudinal Strength Assessed Using Point Compression: Insights From a Second-Generation, Clinically Related Bench Test , 2014, Circulation. Cardiovascular interventions.
[40] K. Yamaji,et al. Incidence and Clinical Impact of Stent Fracture After PROMUS Element Platinum Chromium Everolimus-Eluting Stent Implantation. , 2015, JACC. Cardiovascular interventions.
[41] P. Serruys,et al. Optical coherence tomography analysis of bioresorbable vascular scaffolds in comparison with metallic stents: A core lab perspective , 2017 .
[42] Rui Yang,et al. The Surface Modification Methods for Constructing Polymer-Coated Stents , 2018, International Journal of Polymer Science.
[43] P. Serruys,et al. A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trial , 2017, The Lancet.
[44] H. Schunkert,et al. Five-year outcomes from a trial of three limus-eluting stents with different polymer coatings in patients with coronary artery disease: final results from the ISAR-TEST 4 randomised trial. , 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[45] F. Eberli,et al. Impact of incomplete stent apposition on long-term clinical outcome after drug-eluting stent implantation. , 2012, European heart journal.
[46] M. Togni,et al. Biodegradable Polymer Biolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents in Patients With Coronary Artery Disease: Final 5-Year Report From the COMPARE II Trial (Abluminal Biodegradable Polymer Biolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent). , 2017, JACC. Cardiovascular interventions.
[47] John A Ormiston,et al. Stent longitudinal integrity bench insights into a clinical problem. , 2011, JACC. Cardiovascular interventions.
[48] C. Yen,et al. Quantitative evaluation of susceptibility and shielding effects of nitinol, platinum, cobalt‐alloy, and stainless steel stents , 2003, Magnetic resonance in medicine.
[49] I. Porto,et al. Meta‐analysis of bioabsorbable versus durable polymer drug‐eluting stents in 20,005 patients with coronary artery disease: An update , 2014, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[50] Ryo Torii,et al. Non-Newtonian pulsatile shear stress assessment: a method to differentiate bioresorbable scaffold platforms. , 2017, European heart journal.
[51] M. Mamas,et al. Incidence and mechanisms of longitudinal stent deformation associated with Biomatrix, Resolute, Element, and Xience stents: Angiographic and case‐by‐case review of 1,800 PCIs , 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[52] Bernard Chevalier,et al. Comparison of in vivo acute stent recoil between the bioresorbable everolimus‐eluting coronary scaffolds (revision 1.0 and 1.1) and the metallic everolimus‐eluting stent , 2011, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[53] C. Di Mario,et al. Importance of knowing stent design threshold diameters and post-dilatation capacities to optimise stent selection and prevent stent overexpansion/incomplete apposition during PCI. , 2013, International Journal of Cardiology.
[54] Trina Roy,et al. Computational Modelling and Analysis of Latest Commercially Available Coronary Stents During Deployment , 2014 .
[55] W Rutsch,et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. , 1994, The New England journal of medicine.
[56] Helmut Baumgartner,et al. ESC / EACTS Guidelines on myocardial revascularization , 2014 .
[57] Timothy Watson,et al. Long and short of optimal stent design , 2017, Open Heart.
[58] Renu Virmani,et al. Incidence and predictors of drug-eluting stent fracture in human coronary artery a pathologic analysis. , 2009, Journal of the American College of Cardiology.
[59] Whole Grain Label Statements. Guidance for Industry and FDA Staff , 2006 .
[60] A. Kastrati,et al. Predictive Factors of Restenosis After Coronary Implantation of Sirolimus- or Paclitaxel-Eluting Stents , 2006, Circulation.
[61] Ryo Torii,et al. Incomplete Stent Apposition Causes High Shear Flow Disturbances and Delay in Neointimal Coverage as a Function of Strut to Wall Detachment Distance: Implications for the Management of Incomplete Stent Apposition , 2014, Circulation. Cardiovascular interventions.
[62] H. Bezerra,et al. Impact of acute gain on clinical outcomes of patients treated with sirolimus-eluting stent. - A sub-analysis study from the STLLR trial-. , 2011, Circulation Journal.
[63] K. Seung,et al. Incidence and clinical impact of fracture of drug-eluting stents widely used in current clinical practice: comparison with initial platform of sirolimus-eluting stent. , 2012, Journal of cardiology.
[64] S. Bangalore,et al. Meta-Analysis of Randomized Clinical Trials Comparing Biodegradable Polymer Drug-Eluting Stent to Second-Generation Durable Polymer Drug-Eluting Stents. , 2017, JACC. Cardiovascular interventions.
[65] R. Whitbourn,et al. TAXUS ® Element™ stent system , 2011 .
[66] R. Mongrain,et al. Coronary Stents Fracture: An Engineering Approach (Review) , 2013 .
[67] C. Di Mario,et al. Stent flexibility versus concertina effect: mechanism of an unpleasant trade-off in stent design and its implications for stent selection in the cath-lab. , 2013, International journal of cardiology.
[68] Tom Duerig,et al. Self-expanding nitinol stents: material and design considerations , 2004, European Radiology.
[69] S. Barutçu,et al. Clinical, angiographic and procedural characteristics of longitudinal stent deformation , 2016, The International Journal of Cardiovascular Imaging.
[70] Stephen Moore,et al. Numerical investigations of the haemodynamic changes associated with stent malapposition in an idealised coronary artery. , 2014, Journal of biomechanics.
[71] Antonio Colombo,et al. Selection of coronary stents. , 2002, Journal of the American College of Cardiology.
[72] R. V. van Geuns,et al. Occurrence and predictors of acute stent recoil—A comparison between the xience prime cobalt chromium stent and the promus premier platinum chromium stent , 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[73] F. Ye,et al. Incidence and Clinical Outcomes of Stent Fractures on the Basis of 6,555 Patients and 16,482 Drug-Eluting Stents From 4 Centers. , 2016, JACC. Cardiovascular interventions.
[74] J. Barry,et al. Strut tissue coverage and endothelial cell coverage: a comparison between bare metal stent platforms and platinum chromium stents with and without everolimus-eluting coating. , 2010, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[75] E. Orav,et al. Late Loss in Lumen Diameter and Binary Restenosis for Drug-Eluting Stent Comparison , 2005, Circulation.
[76] C. Simonton,et al. Engineering assessment of the longitudinal compression behaviour of contemporary coronary stents. , 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[77] Meng Chen,et al. Corrosion resistance improvement for 316L stainless steel coronary artery stents by trimethylsilane plasma nanocoatings. , 2014, Journal of biomedical materials research. Part B, Applied biomaterials.
[78] C. Di Mario,et al. Over-expansion capacity and stent design model: An update with contemporary DES platforms. , 2016, International journal of cardiology.
[79] Fred J. Clubb,et al. INCREASED ARTERY WALL STRESS POST-STENTING LEADS TO GREATER INTIMAL THICKENING , 2010, Laboratory Investigation.
[80] Michael S. Lee,et al. Drug‐eluting stent fracture: Incidence, contributing factors, and clinical implications , 2010, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[81] H. Suryapranata,et al. Short and long-term safety and efficacy of polymer-free vs. durable polymer drug-eluting stents. A comprehensive meta-analysis of randomized trials including 6178 patients. , 2014, Atherosclerosis.
[82] G. Finet,et al. Drug-Eluting Stents in Bifurcations: Bench Study of Strut Deformation and Coating Lesions , 2010, Circulation. Cardiovascular interventions.
[83] H. Schunkert,et al. Outcomes of patients treated with ultrathin-strut biodegradable polymer sirolimus-eluting stents versus fluoropolymer-based everolimus-eluting stents: a meta-analysis of randomised trials. , 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[84] J. Ormiston,et al. Coronary stent durability and fracture: an independent bench comparison of six contemporary designs using a repetitive bend test. , 2015, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[85] K. Kadota,et al. Clinical and angiographic outcomes of axial stent deformations in unrestricted real world patient population , 2017, Journal of interventional cardiology.
[86] P. Teirstein,et al. Long-Term Safety and Efficacy of Platinum Chromium Everolimus-Eluting Stents in Coronary Artery Disease: 5-Year Results From the PLATINUM Trial. , 2017, JACC. Cardiovascular interventions.
[87] Marc D Feldman,et al. Coronary stents: a materials perspective. , 2007, Biomaterials.
[88] T. Kume,et al. Impact of stent platform on longitudinal stent deformation: an in vivo frequency domain optical coherence tomography study , 2017, Cardiovascular Intervention and Therapeutics.
[89] C. Terkelsen,et al. Comparison of Durable-Polymer Zotarolimus-Eluting and Biodegradable-Polymer Biolimus-Eluting Coronary Stents in Patients With Coronary Artery Disease: 3-Year Clinical Outcomes in the Randomized SORT OUT VI Trial. , 2017, JACC. Cardiovascular interventions.
[90] S. Silber,et al. Twelve-month results of a prospective, multicentre trial to assess the everolimus-eluting coronary stent system (PROMUS Element): the PLATINUM PLUS all-comers randomised trial. , 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[91] M. Maitz,et al. Plasma-immersion ion-implanted nitinol surface with depressed nickel concentration for implants in blood. , 2006, Journal of biomedical materials research. Part A.
[92] M. Prince,et al. Three‐dimensional MR angiography in imaging platinum alloy stents , 2004, Journal of magnetic resonance imaging : JMRI.
[93] G. Stone,et al. Intravascular ultrasound assessment of cobalt chromium versus stainless steel drug-eluting stent expansion. , 2010, The American journal of cardiology.
[94] Wim E Hennink,et al. Polymer-Free Drug-Eluting Stents: An Overview of Coating Strategies and Comparison with Polymer-Coated Drug-Eluting Stents. , 2015, Bioconjugate chemistry.
[95] Influence of metal alloy and the profile of coronary stents in patients with multivessel coronary disease , 2011, Clinics.
[96] M. Mamas,et al. Longitudinal stent deformation: insights on mechanisms, treatments and outcomes from the Food and Drug Administration Manufacturer and User Facility Device Experience database. , 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[97] E. Orav,et al. Robustness of Late Lumen Loss in Discriminating Drug-Eluting Stents Across Variable Observational and Randomized Trials , 2005, Circulation.
[98] R. Virmani,et al. Comparison of Acute Thrombogenicity for Metallic and Polymeric Bioabsorbable Scaffolds: Magmaris Versus Absorb in a Porcine Arteriovenous Shunt Model , 2017, Circulation. Cardiovascular interventions.
[99] Seung‐Jung Park,et al. Intravascular ultrasound comparison of chronic recoil among different stent designs. , 1999, The American journal of cardiology.
[100] F. Shellock,et al. Drug eluting coronary stent: in vitro evaluation of magnet resonance safety at 3 Tesla. , 2005, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[101] C. Dubois,et al. Clinical utility of platinum chromium bare-metal stents in coronary heart disease , 2015, Medical devices.
[102] R. Stables,et al. Stent expansion: a combination of delivery balloon underexpansion and acute stent recoil reduces predicted stent diameter irrespective of reference vessel size , 2006, Heart.
[103] Bernard Chevalier,et al. Comparison of in vivo acute stent recoil between the bioabsorbable everolimus‐eluting coronary stent and the everolimus‐eluting cobalt chromium coronary stent: Insights from the ABSORB and SPIRIT trials , 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[104] Effect on Clinical Restenosis of an Ultra-Thin-Strut Bare Metal Cobalt-Chromium Stent Versus a Thin-Strut Stainless Steel Stent. , 2016, Journal of interventional cardiology.
[105] A. Kastrati,et al. Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial. , 2003, Journal of the American College of Cardiology.
[106] J. Tanigawa,et al. The influence of strut thickness and cell design on immediate apposition of drug-eluting stents assessed by optical coherence tomography. , 2009, International journal of cardiology.
[107] R. Virmani,et al. Vascular healing in drug-eluting stents: differential drug-associated response of limus-eluting stents in a preclinical model of stent implantation. , 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[108] M. Leoncini,et al. Magmaris: a new generation metallic sirolimus-eluting fully bioresorbable scaffold: present status and future perspectives. , 2017, Journal of thoracic disease.
[109] M. Stoel,et al. Three-year safety and efficacy of treating all-comers with newer-generation Resolute Integrity or PROMUS Element stents in the randomised DUTCH PEERS (TWENTE II) trial. , 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[110] F. Eberli,et al. Improved Safety and Reduction in Stent Thrombosis Associated With Biodegradable Polymer-Based Biolimus-Eluting Stents Versus Durable Polymer-Based Sirolimus-Eluting Stents in Patients With Coronary Artery Disease Final 5-Year Report (Limus Eluted From A Durable Versus ERodable Stent Coating) Randomi , 2022 .
[111] Patrick W Serruys,et al. Bioresorbable Scaffold: The Advent of a New Era in Percutaneous Coronary and Peripheral Revascularization? , 2011, Circulation.
[112] R. Shandas,et al. A Survey of Surface Modification Techniques for Next-Generation Shape Memory Polymer Stent Devices , 2014 .
[113] A. Kastrati,et al. Intracoronary Stenting and Angiographic Results: Strut Thickness Effect on Restenosis Outcome (ISAR-STEREO) Trial , 2001, Circulation.
[114] T. Maruo,et al. Stent Fracture After Sirolimus-Eluting Stent Implantation: 8-Year Clinical Outcomes , 2015, Circulation. Cardiovascular interventions.
[115] A. Baszko,et al. The effect of stent coating on stent deliverability: direct randomised comparison of drug eluting and bare metal stents using the same stent platform. , 2012, Kardiologia polska.
[116] R. Wilensky,et al. Twenty-Year Evolution of Percutaneous Coronary Intervention and Its Impact on Clinical Outcomes: A Report From the National Heart, Lung, and Blood Institute–Sponsored, Multicenter 1985–1986 PTCA and 1997–2006 Dynamic Registries , 2008, Circulation. Cardiovascular interventions.
[117] Junaid Zafar,et al. Medical Stents : State of the Art and Future Directions Coronary Stent Materials and Coatings : A Technology and Performance Update , 2015 .
[118] G. Breithardt,et al. Relationship of Late Loss in Lumen Diameter to Coronary Restenosis in Sirolimus-Eluting Stents , 2005, Circulation.
[119] J. Tijssen,et al. Randomized Multicenter Trial Investigating Angiographic Outcomes of Hybrid Sirolimus-Eluting Stents With Biodegradable Polymer Compared With Everolimus-Eluting Stents With Durable Polymer in Chronic Total Occlusions: The PRISON IV Trial. , 2017, JACC. Cardiovascular interventions.
[120] E. Edelman,et al. Endovascular stent design dictates experimental restenosis and thrombosis. , 1995, Circulation.
[121] T. Murohara,et al. Impact of coronary stent designs on acute stent recoil. , 2014, Journal of cardiology.
[122] G. Stone,et al. Bare Metal and Drug-Eluting Coronary Stents , 2012 .
[123] P. Serruys,et al. How does the failure of Absorb apply to the other bioresorbable scaffolds? An expert review of first-in-man and pivotal trials. , 2019, EuroIntervention.
[124] M. Joner,et al. Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography , 2013, Heart.
[125] R. Virmani,et al. Endothelial cell recovery between comparator polymer-based drug-eluting stents. , 2008, Journal of the American College of Cardiology.
[126] C. Terkelsen,et al. Final five-year outcomes after implantation of biodegradable polymer-coated biolimus-eluting stents versus durable polymer-coated sirolimus-eluting stents. , 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[127] P. E. McHugh,et al. Comparing coronary stent material performance on a common geometric platform through simulated bench testing. , 2012, Journal of the mechanical behavior of biomedical materials.
[128] J. Mehilli,et al. Stent Polymers: Do They Make a Difference? , 2016, Circulation. Cardiovascular interventions.
[129] Jan J Piek,et al. Impact of strut thickness on late luminal loss after coronary artery stent placement. , 2004, The American journal of cardiology.
[130] P. Teirstein,et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. , 1994, The New England journal of medicine.
[131] Qiang Ge,et al. Biodegradable magnesium coronary stents: material, design and fabrication , 2014, Int. J. Comput. Integr. Manuf..
[132] A. Kastrati,et al. Increased risk of restenosis after placement of gold-coated stents: results of a randomized trial comparing gold-coated with uncoated steel stents in patients with coronary artery disease. , 2000, Circulation.
[133] Y. L. Chen,et al. Increased corrosion resistance of stent materials by converting current surface film of polycrystalline oxide into amorphous oxide. , 2000, Journal of biomedical materials research.
[134] N. Lepor. Clinical impact of stent design. , 2003, Reviews in cardiovascular medicine.
[135] P. Serruys,et al. Delineating the Numerous Causes of Drug-Eluting Stent Restenosis , 2011 .
[136] P. Erne,et al. The Road to Bioabsorbable Stents: Reaching Clinical Reality? , 2006, CardioVascular and Interventional Radiology.
[137] D. Shum-Tim,et al. Surface and Electrochemical Characterization of IrTi-Oxide Coatings: Towards the Improvement of Radiopacity for Coronary Stent Applications , 2013, International Journal of Electrochemical Science.
[138] M. Nobuyoshi,et al. Incidence and Clinical Impact of Stent Fracture After Everolimus-Eluting Stent Implantation , 2012, Circulation. Cardiovascular interventions.
[139] M. Pfisterer,et al. A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease. , 2007, Journal of the American College of Cardiology.
[140] R. Virmani,et al. Engineering aspects of stents design and their translation into clinical practice. , 2007, Annali dell'Istituto superiore di sanita.
[141] M. Hadamitzky,et al. Predictive factors of restenosis after coronary stent placement. , 1997, Journal of the American College of Cardiology.
[142] F. Neumann,et al. 'Ten Commandments' for the 2018 ESC/EACTS Guidelines on Myocardial Revascularization. , 2018, European heart journal.
[143] P. Serruys,et al. 4-year clinical outcomes and predictors of repeat revascularization in patients treated with new-generation drug-eluting stents: a report from the RESOLUTE All-Comers trial (A Randomized Comparison of a Zotarolimus-Eluting Stent With an Everolimus-Eluting Stent for Percutaneous Coronary Intervention , 2014, Journal of the American College of Cardiology.
[144] Antonis Sakellarios,et al. Impact of local endothelial shear stress on neointima and plaque following stent implantation in patients with ST-elevation myocardial infarction: A subgroup-analysis of the COMFORTABLE AMI-IBIS 4 trial. , 2015, International journal of cardiology.
[145] Michael Joner,et al. Vascular Responses to Drug Eluting Stents: Importance of Delayed Healing , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[146] Patrick W Serruys,et al. Report of a European Society of Cardiology-European Association of Percutaneous Cardiovascular Interventions task force on the evaluation of coronary stents in Europe: executive summary. , 2015, European heart journal.
[147] P. Fitzgerald,et al. Acute stent recoil and optimal balloon inflation strategy: an experimental study using real-time optical coherence tomography. , 2016, EuroIntervention.
[148] A. Colombo,et al. A Practical Approach to the Management of Complications During Percutaneous Coronary Intervention. , 2018, JACC. Cardiovascular interventions.
[149] Robert Langer,et al. Physical and mechanical properties of PLA, and their functions in widespread applications - A comprehensive review. , 2016, Advanced drug delivery reviews.
[150] F. Eberli,et al. Effects of cobalt-chromium everolimus eluting stents or bare metal stent on fatal and non-fatal cardiovascular events: patient level meta-analysis , 2014, BMJ : British Medical Journal.
[151] E. Romagnoli,et al. Closed versus open cell stent for high-risk percutaneous coronary interventions in ST-elevation acute myocardial infarction: the Closed versus Open Cells stent for High risk percutaneous coronary Interventions in ST-Elevation acute myocardial infarction (COCHISE) pilot study. , 2013, American heart journal.
[152] L. Topoleski,et al. A comparison of the mechanical performance characteristics of seven drug‐eluting stent systems , 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[153] E. Edelman,et al. Stent Thrombogenicity Early in High-Risk Interventional Settings Is Driven by Stent Design and Deployment and Protected by Polymer-Drug Coatings , 2011, Circulation.
[154] M. Mamas,et al. Longitudinal stent deformation: a retrospective analysis of frequency and mechanisms. , 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[155] M. Nobuyoshi,et al. Incidence and Clinical Impact of Stent Fracture After the Nobori Biolimus‐Eluting Stent Implantation , 2014, Journal of the American Heart Association.
[156] C. Jansen,et al. Stent design related neointimal tissue proliferation in human coronary arteries; an intravascular ultrasound study. , 2001, European heart journal.
[157] P. Gurbel,et al. Could stent design affect platelet activation? Results of the Platelet Activation in STenting (PAST) Study. , 2002, The Journal of invasive cardiology.
[158] Gregg W Stone,et al. A prospective, randomized evaluation of a novel everolimus-eluting coronary stent: the PLATINUM (a Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System [PROMUS Element] for the Treatment of Up to Two de Novo Coronary Artery Lesions) trial. , 2011, Journal of the American College of Cardiology.
[159] H. Bøtker,et al. Two-year outcome after biodegradable polymer sirolimus- and biolimus-eluting coronary stents (from the randomised SORT OUT VII trial). , 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[160] Ryo Torii,et al. Impact of stent strut design in metallic stents and biodegradable scaffolds. , 2014, International journal of cardiology.
[161] S. Bangalore. Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease , 2016, The New England journal of medicine.
[162] P. Barragan,et al. Longitudinal compression behaviour of coronary stents: a bench-top comparative study. , 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.